Leahy Wants NIH To Make Myriad License Out Patents

Law360, New York (July 15, 2013, 4:53 PM EDT) -- Sen. Patrick Leahy, D-Vt., urged the National Institutes of Health on Friday to use an obscure statutory procedure to force Myriad Genetics Inc. to license out its patents on man-made DNA, which were upheld as valid by the U.S. Supreme Court last month.

The Vermont Democrat wants NIH to consider using its so-called march-in rights — a never-before-invoked provision of the Bayh-Dole Act that allows government agencies to restrict a patent holder's control of an invention in certain circumstances if the research behind it was federally...
To view the full article, register now.